Korean Journal of Head & Neck Oncology (대한두경부종양학회지)

The Korean Society for Head and Neck Oncology (대한두경부종양학회)
권호 표지

A Study of Predictive Factors of Cervical Lymph Node Metastasis in Papillary Microcarcinoma(PMC) of Thyroid Gland

갑상선 미세유두암에서 경부림프절 전이의 예측인자에 대한 연구

  • Yu, Hye-Mi (Department of Surgery, Busan Paik Hospital, Inje University College of Medicine) ;
  • Ha, Tae-Kwun (Department of Surgery, Busan Paik Hospital, Inje University College of Medicine) ;
  • Ryu, Sung-Mock (Department of Surgery, Busan Paik Hospital, Inje University College of Medicine) ;
  • Kim, Woon-Won (Department of Surgery, Busan Paik Hospital, Inje University College of Medicine) ;
  • Kim, Sang-Hyo (Department of Surgery, Busan Paik Hospital, Inje University College of Medicine)
  • 유혜미 (인제대학교 의과대학 부산백병원 외과학교실) ;
  • 하태권 (인제대학교 의과대학 부산백병원 외과학교실) ;
  • 유성목 (인제대학교 의과대학 부산백병원 외과학교실) ;
  • 김운원 (인제대학교 의과대학 부산백병원 외과학교실) ;
  • 김상효 (인제대학교 의과대학 부산백병원 외과학교실)
  • Published : 2010.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background : Though papillary microcarcinoma(PMC) of thyroid gland is known to have very favorable long-term prognosis, the recurrence in the neck and distant metastasis have been often reported. The predictive factors of node metastasis and tumor recurrence in clinical course were investigated to define surgical decision or guidelines in surgery of papillary microcarcinoma. Methods : The authors conducted a retrospective analysis of 216 patients of PMC treated with surgery at Department of Surgery, Busan Paik Hospital for the period from 1997 to 2007. Of these patients, 58 cases showing cervical lymph node metastasis at initial surgery were studied. Results : In overall 216 patients, the sex ratio of male to female was 1 : 9.3(male 21, female 195 cases), the mean age at the time of diagnosis was 44.7 years and the median tumor size was 6.61mm. Neck lymph node metastasis was found in 58 patients(26.9%), thyroid capsular invasion was 56 cases(25.9%), multifocality and bilaterality were found in 32(14.8%) and 29 cases(13.4%), respectively. Through statistical analysis, sex, capsular invasion, ETE, and tumor size(>5mm) were considered to be predictive factors of cervical lymph nodes metastasis. Of them, capsular invasion was the most predictive indicator of cervical lymph node metastasis on multivariate analysis. Nodal recurrence was observed in 6 of 58 patients of node positive at initial surgery. Conclusion : The cervical lymph node metastasis is known to be a risk factor of prognosis in PMC of thyroid gland. The results of this study showed four statistically significant independent predictive factors of cervical lymph node metastasis in PMC : capsular invasion, tumor size(>5mm), ETE, and sex. On multivariate analysis, capsular invasion was a great influencing factor in prediction of lymph node metastasis. Basically, patients who has predictive factors of cervical lymph node metastasis should have a thorough investigation, and close surveillance for nodal status is required in follow-up.

Keywords

References

  1. Attie JN, setzin M, Klein I. Thyroid carcinoma presenting as an enlarged cervical lymph node. Am J Surg. 1993;166:428-430. https://doi.org/10.1016/S0002-9610(05)80348-4
  2. Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13: 381-387. https://doi.org/10.1089/105072503321669875
  3. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: Addition of the new variables of large nodal metastases and reclassification during the follow- up period. Surgery. 2004;135:139-148. https://doi.org/10.1016/S0039-6060(03)00384-2
  4. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98(1):31-40. https://doi.org/10.1002/cncr.11442
  5. Ito Y, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, et al. Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination. Oncologgy. 2005;68:87-96. https://doi.org/10.1159/000085701
  6. Besic N, Pilko G, Petric R, Hocevar M, Zgajnar J. Papillary thyroid microcarcinoma; Prognostic factors and treatment. J Surg Oncol. 2008;97:221-225.
  7. Pellegriti G, Scollo C, Lunmera G, Regallbuto C, Viqneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5cm in diameter: Study of 299 cases. J Clin Endocrinol Metab. 2004;89:3713-3720. https://doi.org/10.1210/jc.2003-031982
  8. Byar DP, Green SB, Dor P. A prognostic index for thyroid carcinoma: A study of the E.O. R, T, C thyroid cancer cooperative group. Europ J Cancer. 1979;43:810.
  9. Cady B, Sedwick CE, Meisner WA. Risk factor analysis in differentiated thyroid cancer. Cancer. 1979;43:810. https://doi.org/10.1002/1097-0142(197903)43:3<810::AID-CNCR2820430306>3.0.CO;2-B
  10. Arona N, Tubendian HK, Kato MA, Moo TA, Zarnegar R, Faheg TJ. Papillary thyroid carcinoma and microcarcinoma: Is There a Need to Distinguish the Two? Thyroid. 2009;19(5):473- 477. https://doi.org/10.1089/thy.2008.0185
  11. Kasai N, Sakamoto A. New subgrouping of small thyroid carcinomas. Cancer. 1987;60(8):1767-70. https://doi.org/10.1002/1097-0142(19871015)60:8<1767::AID-CNCR2820600816>3.0.CO;2-P
  12. Machens A, Holzhausen HJ, Dralle H. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer. 2005;103:2269-2273. https://doi.org/10.1002/cncr.21055
  13. Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, et al. Clinical and histological characteristics of papillary thyroid microcarcinoma: Results of a retrospective study 243 patients. J Clin Endocrinol Metab. 2006;91:2171-2178. https://doi.org/10.1210/jc.2005-2372
  14. Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13: 381-387. https://doi.org/10.1089/105072503321669875
  15. Rosai J, Carangiu ML, Delelis RA. Tumors of the thyroid gland. In: Atlas of tumor pathology, 3rd edition, fascicle 5, AFIP, Washington DC;1992. p.65-121.
  16. Sobin LH, Wittekind C. Head and neck Tumors. In: TNM Classification of malignant Tumors, Sixth edition John Wiley & Sons, New York;2002. p.52-56.
  17. Appetecchia M, Scarcello G, Pucci E, Procaccin-A. Outcome after treatment of papillary thyroid microcarcinoma. J Exp Clin Cancer Res. 2002;21(2):159-164.
  18. Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Pianna S, et al. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: Results of a study in 445 patients: Thyroid. 2009;19 (7):707-716. https://doi.org/10.1089/thy.2008.0270
  19. Pelizzo MR, Merante Boschin I, Toniato A, Paqetta C, Piotto A, Bernante P, et al. Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma(PTMC); A mono-institutional 12-year experience. Nucl Med Commun. 2004;25:547- 552. https://doi.org/10.1097/01.mnm.0000126625.17166.36
  20. Yamashita H, Noguchi S, Murokami N, Toda M, Uchino S, Watanabe S, et al. Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer. 1999;86:842-849. https://doi.org/10.1002/(SICI)1097-0142(19990901)86:5<842::AID-CNCR21>3.0.CO;2-X
  21. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, et al. Lymph node metastasis from 259 papillary thyroid microcarcinoma; Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237: 399-407.
  22. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:1447-1463. https://doi.org/10.1210/jc.86.4.1447
  23. Baudin E, Travaqli JP, Ropers J, Mancusi F, Bruno-Bois G, Caillou B, et al. Microcarcinoma of the thyroid gland: The Gustave- Roussy Institute experience. Cancer. 1998;83:553-559. https://doi.org/10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO;2-U
  24. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg. 2006;30:91-99. https://doi.org/10.1007/s00268-005-0113-y
  25. Baudin E, Travagli JP, Roperts J, Mancusi F, Bruno-Bossio G, Caillou B, et al. Microcarcinoma of the thyroid gland: The Gustave Roussy Institute experience. Cancer. 1998;83:553-559. https://doi.org/10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO;2-U
  26. Mazzaferri EL. Long-term outcome of patients with differentiated thyroid carcinoma: Effect of therapy. Endocri Pract. 2000;6:469- 476. https://doi.org/10.4158/EP.6.6.469
  27. Barbaro D, Simit U, Meucci G, Lapi P, Orsini P, Pasquini C. Thyroid papillary cancers: Microcarcinoma and carcinoma, incidental cancers and non-incidental cancers are they different disease? Clinical Endocrinology. 2005;63:577-581. https://doi.org/10.1111/j.1365-2265.2005.02386.x
  28. Gardner RE, Tuttle RM, Burman KD, Haddady S, Truman C, Sparling YH. Prognostic importance of vascular invasion in papillary thyroid carcinoma. Arch Otolaryngol Head and Neck Surg. 2000;126:309-312. https://doi.org/10.1001/archotol.126.3.309
  29. Hay ID, Grant CS, Van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: A study of 53 cases observed in a 50-year period. Surgery. 1992;112:1139-1146.